Apogee Therapeutics, Inc. (APGE) SEC filings
APGE SEC filings moved a median of +0.25% by the close. APGE SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the APGE overview →
73 measured APGE SEC filing events.
Where these APGE SEC filings landedvs 67 measured APGE SEC filing reactions
| Middle 50% of APGE SEC filing reactions | -0.98% to +1.64% |
|---|---|
| Median reaction (to close) | +0.25% |
| Measured reactions | 67 |
Point-in-time · zero look-ahead
Half of the 67 APGE SEC filing events with a measured close landed between -0.98% and +1.64%; 58% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 15-12G Apogee Therapeutics, | SEC filing · Form 15-12G | — | — | |
| Form 8-K Apogee Therapeutics, For: Sep 03 | SEC filing · Form 8-K | — | — | |
| Form POSASR Apogee Therapeutics, | SEC filing · Form POSASR | — | — | |
| Form S-8 POS Apogee Therapeutics, | SEC filing · Form S-8 | — | — | |
| Form 8-K Apogee Therapeutics, For: Aug 11 | SEC filing · Form 8-K | -0.04% | -0.08% | |
| Form 10-Q Apogee Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +0.01% | — | |
| Form 8-K Apogee Therapeutics, For: Aug 10 | SEC filing · Form 8-K | +0.01% | — | |
| Form DEFA14A Apogee Therapeutics, | SEC filing · Form DEFA14A | -0.00% | +0.12% | |
| Form DEFA14A Apogee Therapeutics, | SEC filing · Form DEFA14A | -0.02% | -0.04% | |
| Form DEFM14A Apogee Therapeutics, | SEC filing · Form DEFM14A | -0.10% | -0.03% | |
| Form PREM14A Apogee Therapeutics, For: Jul 02 | SEC filing · Form PREM14A | -0.01% | +0.25% | |
| Form DEFA14A Apogee Therapeutics, | SEC filing · Form DEFA14A | +0.02% | -0.07% | |
| Form 8-K Apogee Therapeutics, For: Jun 17 | SEC filing · Form 8-K | +0.13% | +0.00% | |
| Form 8-K Apogee Therapeutics, For: Jun 18 | SEC filing · Form 8-K | +0.13% | +0.00% | |
| Form DEFA14A Apogee Therapeutics, | SEC filing · Form DEFA14A | +0.13% | +0.00% | |
| Form 8-K Apogee Therapeutics, For: Jun 09 | SEC filing · Form 8-K | -1.34% | -3.87% | |
| Form 8-K Apogee Therapeutics, For: May 26 | SEC filing · Form 8-K | +1.59% | -0.95% | |
| Form 8-K Apogee Therapeutics, For: May 27 | SEC filing · Form 8-K | +1.59% | -0.95% | |
| Form 10-Q Apogee Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +0.01% | +0.73% | |
| Form 8-K Apogee Therapeutics, For: May 11 | SEC filing · Form 8-K | +0.01% | +0.73% | |
| Form 8-K Apogee Therapeutics, For: Apr 21 | SEC filing · Form 8-K | +0.39% | +1.24% | |
| Form ARS Apogee Therapeutics, For: Dec 31 | SEC filing · Form ARS | +0.39% | +1.24% | |
| Form DEF 14A Apogee Therapeutics, For: Jun 09 | SEC filing · Form DEF | +0.39% | +1.24% | |
| Form DEFA14A Apogee Therapeutics, | SEC filing · Form DEFA14A | +0.39% | +1.24% | |
| Form 8-K Apogee Therapeutics, For: Mar 24 | SEC filing · Form 8-K | +1.19% | +1.66% | |
| Form 8-K Apogee Therapeutics, For: Mar 23 | SEC filing · Form 8-K | +2.36% | +2.91% | |
| Form 10-K Apogee Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +0.57% | +4.44% | |
| Form 8-K Apogee Therapeutics, For: Mar 02 | SEC filing · Form 8-K | +0.57% | +4.44% | |
| Form S-8 Apogee Therapeutics, | SEC filing · Form S-8 | +0.57% | +4.44% | |
| Form 8-K Apogee Therapeutics, For: Jan 06 | SEC filing · Form 8-K | +0.09% | +4.33% | |
| Form 10-Q Apogee Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.98% | +1.01% | |
| Form 8-K Apogee Therapeutics, For: Nov 10 | SEC filing · Form 8-K | +0.98% | +1.01% | |
| Form 8-K Apogee Therapeutics, For: Oct 08 | SEC filing · Form 8-K | +0.00% | -1.00% | |
| Form 10-Q Apogee Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -0.69% | -2.09% | |
| Form 8-K Apogee Therapeutics, For: Aug 11 | SEC filing · Form 8-K | -0.69% | -2.09% | |
| Form 8-K Apogee Therapeutics, For: Jul 07 | SEC filing · Form 8-K | -11.13% | -16.99% | |
| Form 8-K Apogee Therapeutics, For: Jun 17 | SEC filing · Form 8-K | +0.58% | +0.17% | |
| Form 10-Q Apogee Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -1.49% | +0.23% | |
| Form 8-K Apogee Therapeutics, For: May 12 | SEC filing · Form 8-K | -1.49% | +0.23% | |
| Form ARS Apogee Therapeutics, For: Dec 31 | SEC filing · Form ARS | -0.32% | +6.05% | |
| Form DEF 14A Apogee Therapeutics, For: Jun 17 | SEC filing · Form DEF | -0.32% | +6.05% | |
| Form DEFA14A Apogee Therapeutics, | SEC filing · Form DEFA14A | -0.32% | +6.05% | |
| Form 8-K Apogee Therapeutics, For: Mar 10 | SEC filing · Form 8-K | +0.59% | +7.27% | |
| Form 10-K Apogee Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +6.06% | -3.89% | |
| Form 8-K Apogee Therapeutics, For: Mar 03 | SEC filing · Form 8-K | +6.06% | -3.89% | |
| Form S-8 Apogee Therapeutics, | SEC filing · Form S-8 | +6.06% | -3.89% | |
| Form 8-K Apogee Therapeutics, For: Feb 03 | SEC filing · Form 8-K | +1.70% | +0.67% | |
| Form 8-K Apogee Therapeutics, For: Dec 10 | SEC filing · Form 8-K | -2.25% | -1.95% | |
| Form 8-K Apogee Therapeutics, For: Dec 02 | SEC filing · Form 8-K | +3.56% | +0.85% | |
| Form 10-Q Apogee Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -0.61% | -4.80% | |
| Form 8-K Apogee Therapeutics, For: Nov 12 | SEC filing · Form 8-K | -0.61% | -4.80% | |
| Form 8-K Apogee Therapeutics, For: Oct 24 | SEC filing · Form 8-K | -0.69% | +0.25% | |
| Form 8-K Apogee Therapeutics, For: Aug 19 | SEC filing · Form 8-K | +0.48% | +10.12% | |
| Form 10-Q Apogee Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +1.80% | +11.21% | |
| Form 8-K Apogee Therapeutics, For: Aug 12 | SEC filing · Form 8-K | +1.80% | +11.21% | |
| Form S-3ASR Apogee Therapeutics, | SEC filing · Form S-3ASR | -0.23% | +0.61% | |
| Form S-8 Apogee Therapeutics, | SEC filing · Form S-8 | -0.23% | +0.61% | |
| Form 8-K Apogee Therapeutics, For: Jun 05 | SEC filing · Form 8-K | +1.70% | +6.84% | |
| Form 8-K Apogee Therapeutics, For: May 24 | SEC filing · Form 8-K | +2.49% | -0.69% | |
| Form DEFA14A Apogee Therapeutics, | SEC filing · Form DEFA14A | +2.49% | -0.69% | |
| Form 8-K Apogee Therapeutics, For: May 15 | SEC filing · Form 8-K | +2.15% | +1.63% | |
| Form 10-Q Apogee Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -0.18% | -2.48% | |
| Form 8-K Apogee Therapeutics, For: May 13 | SEC filing · Form 8-K | -0.18% | -2.48% | |
| Form S-8 Apogee Therapeutics, | SEC filing · Form S-8 | -0.18% | -2.48% | |
| Form ARS Apogee Therapeutics, For: Dec 31 | SEC filing · Form ARS | -0.75% | +1.19% | |
| Form DEF 14A Apogee Therapeutics, For: Jun 05 | SEC filing · Form DEF | -0.75% | +1.19% | |
| Form DEFA14A Apogee Therapeutics, | SEC filing · Form DEFA14A | -0.75% | +1.19% | |
| Form 8-K Apogee Therapeutics, For: Mar 25 | SEC filing · Form 8-K | +0.79% | -5.58% | |
| Form EFFECT Apogee Therapeutics, | SEC filing · Form EFFECT | -1.35% | +1.72% | |
| Form S-1MEF Apogee Therapeutics, | SEC filing · Form S-1MEF | -1.35% | +1.72% | |
| Form 10-K Apogee Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +4.26% | -1.17% | |
| Form 8-K Apogee Therapeutics, For: Mar 05 | SEC filing · Form 8-K | +4.26% | -1.17% | |
| Form S-1 Apogee Therapeutics, | SEC filing · Form S-1 | +0.93% | +9.19% |
Keep exploring
More APGE: earnings → · analyst actions → · APGE overview →